FDA Approves GlaxoSmithKline's HIV Drug

... that our singular focus on HIV can deliver important new medicines, maintaining our absolute commitment to the HIV/AIDS global response," said Dr The submission included data from four pivotal Phase III clinical trials that treated 2,557 adults (who ...

http://www.biospace.com/news_story.aspx?StoryID=305702&full=1